FDA advisers vote in favor of Pfizer’s maternal RSV vaccine By: MarketWatch May 18, 2023 at 18:10 PM EDT If approved, vaccine would be the first in U.S. to protect babies against leading cause of hospitalization Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Pfizer Sanofi-Aventis S.A. ADR
